AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Kannada actor held for smuggling gold worth Rs 12 cr from Dubai

Rahul Dravid’s car hit by goods-laden auto in Bengaluru, video goes viral